Expansion opportunities AvKARE serves DOD, VA, VHA, NIH, CDC, HHS, all US Armed Forces, and state/local customers, indicating a broad government and large-institution footprint ripe for expanded distribution and contract-based growth with additional hospitals, clinics, and defense supply programs.

Recall risk awareness Recent voluntary recalls of eye care products and other ophthalmic OTC items highlight a need for enhanced quality assurance, supplier diversification, and proactive product monitoring programs – a potential selling point for comprehensive quality control and infection-control product lines.

Infection control expansion The launch of AvKARE’s own line of infection control products presents cross-sell potential to hospital pharmacies and contractors already relying on their unit dose and bulk offerings, enabling bundled solutions across sterile and non-sterile product categories.

Contract-driven growth Holding multiple GPO, FSS, and national contracts suggests strong procurement leverage and favorable purchasing terms; selling opportunities exist in aligning additional generics and hospital-grade consumables to these contracting vehicles.

Geographic & channel growth New distribution partnerships, such as with R&S Northeast to expand Glasgow coverage, point to potential channel-focused sales plays in regional markets and through distributor networks to accelerate penetration of hospital and retail pharmacies nationwide.